World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
33761
World Ranking
8638
National Ranking
4455

Paola Dal Cin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paola Dal Cin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 437 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paola Dal Cin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paola Dal Cin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paola Dal Cin is affiliated with Harvard Medical School in the United States. Their research primarily focuses on medicine, with a strong emphasis on hematology, genetics, rheumatology, pathology and forensic medicine, and pulmonary and respiratory medicine.

The main topics of their work include acute myeloid leukemia research, lymphoma diagnosis and treatment, myeloproliferative neoplasms diagnosis and treatment, chronic myeloid leukemia treatments, cancer genomics and diagnostics, chronic lymphocytic leukemia research, and urologic and reproductive health conditions.

Dal Cin has published extensively in a range of scientific venues. The most frequent publication venues are:

  • Modern Pathology
  • Blood Advances
  • American Journal of Hematology
  • The American Journal of Surgical Pathology
  • Blood

Some notable recent papers by Dal Cin include:

  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data (2022, Blood)
  • TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML (2022, Blood Advances)
  • Guiding the global evolution of cytogenetic testing for hematologic malignancies (2022, Blood)
  • Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells (2020, Haematologica)
  • Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia (2020, Blood Advances)

Dal Cin has collaborated frequently with several coauthors, including:

  • Valentina Nardi
  • Robert P. Hasserjian
  • Gabriela Hobbs
  • Adrian M. Dubuc
  • Andrew M. Brunner

Best Publications

  • Ebola virus entry requires the cholesterol transporter Niemann–Pick C1

    Jan E Carette;Jan E Carette;Matthijs Raaben;Anthony C. Wong;Andrew S. Herbert

  • The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

    Kerry J. Savage;Stefano Monti;Jeffery L. Kutok;Giorgio Cattoretti

  • Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

    Stefano Monti;Kerry J. Savage;Jeffery L. Kutok;Friedrich Feuerhake

  • Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

    James E. Butrynski;David R. D’Adamo;Jason L. Hornick;Paola Dal Cin

  • TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

    Brandon Lawrence;Antonio Perez-Atayde;Michele K. Hibbard;Brian P. Rubin

  • The der(17)t(x;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Marc Ladanyi;Man Yee Lui;Cristina R Antonescu;Amber Krause-Boehm

  • BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.

    Jing Deng;Nicole Carlson;Kunihiko Takeyama;Paola Dal Cin

  • Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma

    Jason L. Hornick;Paola Dal Cin;Christopher D.M. Fletcher

  • EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene

    Cristina R. Antonescu;Lei Zhang;Ning En Chang;Bruce R. Pawel

  • Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors

    David Gisselsson;Tord Jonson;Åsa Petersén;Bodil Strömbeck

  • Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity

    David Gisselsson;Louise Pettersson;Mattias Höglund;Markus Heidenblad

  • B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

    Matija Snuderl;Olga K. Kolman;Yi Bin Chen;Jessie J. Hsu

  • Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

    Akinori Yoda;Yuka Yoda;Sabina Chiaretti;Michal Bar-Natan

  • Predominance of Beta-Catenin Mutations and Beta-Catenin Dysregulation in Sporadic Aggressive Fibromatosis (Desmoid Tumor)

    Sabine Tejpar;Friedel Nollet;Catherine Li;Jay S Wunder

  • Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors

    Jason I. Koontz;A. Lee Soreng;Marisa Nucci;Frank C. Kuo

  • MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.

    Leona A Doyle;Emely Möller;Paola Dal Cin;Christopher D M Fletcher

  • USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst

    Andre M. Oliveira;Andre M. Oliveira;Bae Li Hsi;Stanislawa Weremowicz;Andrew E. Rosenberg

  • Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition

    Jan A. Burger;Dan A. Landau;Amaro Taylor-Weiner;Ivana Bozic

  • Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.

    Tobias Sjöblom;Akira Shimizu;Kevin P. O’Brien;Kristian Pietras

  • Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data

    Lu Wang;Toru Motoi;Raya Khanin;Adam Olshen

Frequent Co-Authors

Christopher D.M. Fletcher
Christopher D.M. Fletcher Brigham and Women's Hospital
Avery A. Sandberg
Avery A. Sandberg Roswell Park Cancer Institute
Raf Sciot
Raf Sciot KU Leuven
Jonathan A. Fletcher
Jonathan A. Fletcher Brigham and Women's Hospital
Cynthia C. Morton
Cynthia C. Morton Brigham and Women's Hospital
Fredrik Mertens
Fredrik Mertens Lund University
Nils Mandahl
Nils Mandahl Lund University
Donna Neuberg
Donna Neuberg Harvard University
Jason L. Hornick
Jason L. Hornick Brigham and Women's Hospital
Jon C. Aster
Jon C. Aster Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees and alternative career pathways can broaden options for students interested in healthcare. For those seeking advanced research roles or faculty positions, online nursing PhD programs offer flexible ways to earn a doctoral degree while gaining specialized expertise.

Registered Nurses looking to move up in their careers often consider obtaining a Bachelor of Science in Nursing. The cheapest RN to BSN online programs make this step more accessible and affordable, enabling nurses to qualify for leadership and advanced clinical roles.

For individuals with a non-nursing bachelor’s degree, direct MSN programs online provide a streamlined option to transition into nursing at the graduate level. These programs can be completed quickly and fully online, making it easier than ever to switch careers.

Those evaluating where to begin their healthcare journey may also explore direct entry nursing programs. These programs can have less stringent admission requirements, helping students begin their path into medicine or nursing sooner.

Best Scientists Citing Paola Dal Cin

Trending Scientists

Recently Published Articles